Wire Stories

? Dr Jai Das and Dr Muhammad Salman selected to receive a Falcon Award for Disease Elimination ? They will…

4 years ago

Cyril Amarchand Mangaldas announces the opening of its Singapore Foreign Law Practice

MUMBAI--(BUSINESS WIRE)--#CAM--India�s leading law firm, Cyril Amarchand Mangaldas (CAM) announced today the opening of its new foreign law practice in…

4 years ago

SOPA 2022 Journalism Awards Open for Entries; Deadline 17 Feb

HONG KONG--(BUSINESS WIRE)--#SOPAwards2022--The Society of Publishers in Asia (SOPA), a not-for-profit organization dedicated to the pursuit of excellence in journalism,…

4 years ago

Murata and Michelin Co-develop RFID Module to Improve Tire Management Operations

Michelin co-develops RFID module to improve tire management operations KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO:6981) (ISIN:JP3914400001) has co-developed a…

4 years ago

GOYANG, South Korea--(BUSINESS WIRE)--#BioPharmaExhibition--KOREA PACK and concurrent event ICPI WEEK (Int�l Cosmetic and Pharmaceutical Industry Week) will be held as…

4 years ago

Confluent and Alibaba Cloud Announce Partnership to set Data in Motion in Mainland China

SINGAPORE--(BUSINESS WIRE)--Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, and Alibaba Cloud, the digital technology and intelligence backbone…

4 years ago

GLIDE: End of Malaria and Lymphatic Filariasis in Sight for Philippines, Says Award-winning Filipino Doctor

? Dr Fe Esperanza Espino is one of five winners selected to win a Falcon Award for Disease Elimination ?…

4 years ago

Understanding the Hehe Culture and A Community of Shared Future for Mankind in Taizhou, Zhejiang

TAIZHOU, China--(BUSINESS WIRE)--Themed �Hehe Culture and A Community of Shared Future for Mankind�, the 2021 Hehe Culture Global Forum was…

4 years ago

BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting

BRUKINSA demonstrated superiority in progression-free survival over chemoimmunotherapy as a first-line treatment for patients with chronic lymphocytic leukemia Consistent efficacy…

4 years ago

Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma

Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory ATL Orphan Drug Designation granted…

4 years ago